Jinhan He, Shigeru Nishida, Meishu Xu, Makoto Makishima, Wen Xie 

Slides:



Advertisements
Similar presentations
Volume 134, Issue 7, Pages (June 2008)
Advertisements

Peter L. Lee, Yuefeng Tang, Huawei Li, David A. Guertin 
Volume 133, Issue 3, Pages (September 2007)
Alas! Ileal Interposition Surgery for Diabetes Prevention?
Covering the Cover Gastroenterology
Volume 2, Issue 4, Pages (October 2005)
Volume 131, Issue 2, Pages (August 2006)
The FXR-FGF19 Gut–Liver Axis as a Novel “Hepatostat”
Volume 146, Issue 4, Pages (April 2014)
Volume 131, Issue 5, Pages (November 2006)
Volume 134, Issue 2, Pages e1 (February 2008)
Volume 20, Issue 3, Pages (July 2017)
Volume 132, Issue 3, Pages (March 2007)
Volume 134, Issue 7, Pages (June 2008)
Volume 14, Issue 1, Pages (July 2011)
Volume 146, Issue 4, Pages (April 2014)
Volume 142, Issue 7, Pages e6 (June 2012)
Volume 132, Issue 3, Pages (March 2007)
Covering the Cover Gastroenterology
Homing in on bile acid physiology
Yingben Xue, James C. Fleet  Gastroenterology 
Volume 129, Issue 2, Pages (August 2005)
Gallstone Disease and Cancer Risk: Finding the Bug in the System
Volume 146, Issue 5, Pages (May 2014)
Aryl Hydrocarbon Receptor Regulates Pancreatic IL-22 Production and Protects Mice From Acute Pancreatitis  Jing Xue, David T.C. Nguyen, Aida Habtezion 
Volume 102, Issue 6, Pages (September 2000)
Reduced Expression of Ferroportin-1 Mediates Hyporesponsiveness of Suckling Rats to Stimuli That Reduce Iron Absorption  Deepak Darshan, Sarah J. Wilkins,
Teruaki Fujishita, Masahiro Aoki, Makoto M. Taketo  Gastroenterology 
Volume 124, Issue 1, Pages (January 2003)
Amani Al-Khaifi, Mats Rudling, Bo Angelin  Gastroenterology 
Volume 134, Issue 7, Pages (June 2008)
Volume 140, Issue 5, Pages (May 2011)
Targeting the FXR Nuclear Receptor to Treat Liver Disease
Volume 121, Issue 6, Pages (December 2001)
Volume 129, Issue 5, Pages (November 2005)
Volume 141, Issue 4, Pages e5 (October 2011)
Regulation of Bile Acid Synthesis by the Nuclear Receptor Rev-erbα
Volume 140, Issue 5, Pages (May 2011)
Volume 137, Issue 4, Pages (October 2009)
Covering the Cover Gastroenterology
Estrogen receptor α, but not β, plays a major role in 17β-estradiol-induced murine cholesterol gallstones  Helen H. Wang, Nezam H. Afdhal, David Q.-H.
Evidence That Gallbladder Epithelial Mucin Enhances Cholesterol Cholelithogenesis in MUC1 Transgenic Mice  Helen H. Wang, Nezam H. Afdhal, Sandra J. Gendler,
Volume 140, Issue 4, Pages e1 (April 2011)
Volume 17, Issue 2, Pages (February 2013)
Volume 143, Issue 6, Pages e8 (December 2012)
DCo(H2)ding the Metabolic Functions of SIRT1 in the Intestine
This Month in Gastroenterology
Volume 142, Issue 4, Pages e2 (April 2012)
Daniel F. Wallace, Lesa Summerville, V. Nathan Subramaniam 
Volume 132, Issue 5, Pages (May 2007)
PPARβ/δ Activation Induces Enteroendocrine L Cell GLP-1 Production
Volume 126, Issue 3, Pages (March 2004)
Alas! Ileal Interposition Surgery for Diabetes Prevention?
Chronic Diarrhea Due to Excessive Bile Acid Synthesis and Not Defective Ileal Transport: A New Syndrome of Defective Fibroblast Growth Factor 19 Release 
Volume 137, Issue 4, Pages (October 2009)
Covering the Cover Gastroenterology
Volume 17, Issue 6, Pages (June 2013)
Volume 137, Issue 4, Pages (October 2009)
Ling Zheng, Terrence E. Riehl, William F. Stenson  Gastroenterology 
Volume 146, Issue 2, Pages (February 2014)
Russell K. Soon, Jim S. Yan, James P. Grenert, Jacquelyn J. Maher 
This Month in Gastroenterology
Volume 131, Issue 5, Pages (November 2006)
Covering the Cover Gastroenterology
James L. Boyer, Carol J. Soroka  Gastroenterology 
Volume 140, Issue 3, Pages (March 2011)
Volume 133, Issue 3, Pages (September 2007)
Volume 141, Issue 5, Pages (November 2011)
Homing in on bile acid physiology
Controversies in Liver Transplantation for Hepatitis C
Presentation transcript:

PXR Prevents Cholesterol Gallstone Disease by Regulating Biosynthesis and Transport of Bile Salts  Jinhan He, Shigeru Nishida, Meishu Xu, Makoto Makishima, Wen Xie  Gastroenterology  Volume 140, Issue 7, Pages 2095-2106 (June 2011) DOI: 10.1053/j.gastro.2011.02.055 Copyright © 2011 AGA Institute Terms and Conditions

Figure 1 Loss of PXR sensitized mice to CGD. Male WT and PXR−/− mice were subjected to lithogenic diet for 4 weeks. (A) Incidence of gallstones with the numbers of mice labeled. (B) Gross appearance of representative gallbladders. (C) Polarizing light microscopic examination of cholesterol crystals. (D) Histological examination of the gallbladder by H&E staining. The arrow indicates the thickness of the gallbladder wall and stromal granulocyte infiltration. The arrowhead indicates submucosal vasodilatation. Gastroenterology 2011 140, 2095-2106DOI: (10.1053/j.gastro.2011.02.055) Copyright © 2011 AGA Institute Terms and Conditions

Figure 2 Loss of PXR altered the biochemical composition of the gallbladder bile, and affected bile flow and biliary lipid outputs. (A, B) The concentrations of bile acids (A, left panel), phospholipids (A, right panel), and cholesterol (B, left panel) in the gallbladder bile, as well as the cholesterol saturation index (B, right panel). Mice were the same as those used in Figure 1. (C−F) Biliary bile acid output (C), phospholipid output (D), bile flow rate (E), and cholesterol output (F), as measured bile duct cannulation. Insert in (C) is the bile acid pool size. n = 7 for each group. *P < .05; **P < .01. Gastroenterology 2011 140, 2095-2106DOI: (10.1053/j.gastro.2011.02.055) Copyright © 2011 AGA Institute Terms and Conditions

Figure 3 Loss of PXR altered the basal and lithogenic diet responsive expression of bile acid transporters. (A) Hepatic messenger RNA (mRNA) expression of bile acid transporters as measured by real-time polymerase chain reaction. (B) Urinary levels of bile acids. (C) Ileal mRNA expression of bile acid transporters. (D) Fecal output of bile acids. n = 7 for each group. *P < .05; **P < .01. (E) Expression of hepatic (left panel) and ileal (right panel) bile acid transporter proteins was measured by Western blot analysis. The relative average protein level was determined by densitometry and labeled underneath the bands. Gastroenterology 2011 140, 2095-2106DOI: (10.1053/j.gastro.2011.02.055) Copyright © 2011 AGA Institute Terms and Conditions

Figure 4 Effect of loss of PXR on the expression of cholesterol and phospholipid transporters and genes involved in bile acid synthesis. (A, B) Hepatic expression of phospholipid transporters (A), and hepatic and ileum expression of cholesterol transporters (B) as measured by real-time polymerase chain reaction. (C) Hepatic expression bile acid synthesis enzyme genes. (D) Expression of Cyp7a1 protein was measured by Western blot analysis. (E) SHP and Fgf15 messenger RNA (mRNA) expression in the ileum (top panel), and Fgf15 protein expression in the serum and ileum (bottom panel). (F) Hepatic mRNA expression of Fgfr4 and β-Klotho. n = 5 for each group. *P < .05; **P < .01. Gastroenterology 2011 140, 2095-2106DOI: (10.1053/j.gastro.2011.02.055) Copyright © 2011 AGA Institute Terms and Conditions

Figure 5 Pharmacological activation of PXR prevented CGD in C57L mice. (A) Incidence of gallstones in male C57L mice treated with vehicle (Veh), PCN, or SJW. All mice were fed with lithogenic diet for 1 week. The numbers of mice are labeled. (B) Microscopic examination of cholesterol crystals. (C, D) Biliary concentrations of bile acids (C, left panel), cholesterol (C, right panel), and phospholipids (D). (E) Calculated cholesterol saturation index. (F) Histological examination of the gallbladder by H&E staining. *P < .05. Gastroenterology 2011 140, 2095-2106DOI: (10.1053/j.gastro.2011.02.055) Copyright © 2011 AGA Institute Terms and Conditions

Figure 6 Pharmacological activation of PXR resulted in a pattern of gene expression favorable for antilithogenesis. Messenger RNA (mRNA) expression of bile acid transporters in the (A) liver and (B) ileum as measured by real-time polymerase chain reaction. Mice were the same as those used in Figure 5. (C) Serum bile acid levels. (D) The mRNA expression bile acid synthesis enzyme genes. (E) Ileal mRNA expression of SHP and Fgf15. n = 5 for each group. *P < .05; **P < .01. Gastroenterology 2011 140, 2095-2106DOI: (10.1053/j.gastro.2011.02.055) Copyright © 2011 AGA Institute Terms and Conditions

Figure 7 Summary of the major gene regulation in PXR−/− mice that may have contributed to the lithogenic phenotype. Shaded and open ovals indicated genes that were down-regulated and up-regulated, respectively, in lithogenic diet-fed PXR−/− mice. Open rectangles indicate genes whose expression was not affected. The gene regulation, in conjunction with the lithogenic diet, led to decreased biliary concentrations of bile acids and phospholipids, increased CSI, and sensitization to CGD. Gastroenterology 2011 140, 2095-2106DOI: (10.1053/j.gastro.2011.02.055) Copyright © 2011 AGA Institute Terms and Conditions